
Avenue Therapeutics, Inc.
Avenue Therapeutics, Inc. (ATXI) Stock Overview
Key statistics and deep links to earnings, valuation, revenue, dividends, and more.
FMP · ATXI · as of Jun 8, 2026
Key Statistics
Explore Avenue Therapeutics, Inc. Data
atxi stock data · financialsFinancial Snapshot
Full FinancialsAnalyst Ratings & Price Target
Full ForecastTotal: 1 · Buy rate: 100.0%
The ATXI analyst consensus is Buy, based on ratings from 1 Wall Street analysts over the past 3 months. The average 12-month price target is $12.00, representing +3770.97% upside from the current price of $0.31.
Competitors & Peers
atxi competitorsStock Performance
Full HistoryAbout Avenue Therapeutics, Inc.
Avenue Therapeutics, Inc. functions as a specialized pharmaceutical enterprise, primarily dedicated to innovating and bringing to market medical therapies tailored for critical and intensive care envi…
what is avenue therapeutics, inc. · atxi stock overview · avenue therapeutics, inc. company profile · who is avenue therapeutics, inc. ceo · atxi OTC · avenue therapeutics, inc. headquarters · avenue therapeutics, inc. business segments
About Stock Overview & Key Data
Avenue Therapeutics, Inc. (ATXI) is a Healthcare company in the Biotechnology industry, listed on OTC since Jun 27, 2017. As of the latest trading session, ATXI stock price is $0.31, with a market capitalization of $1.0M. The stock has returned +54.46% over the past 12 months and -54.43% year-to-date.
According to 1 Wall Street analysts, the consensus rating for Avenue Therapeutics, Inc. stock is Buy, with an average 12-month price target of $12.00. In fiscal year 2025, Avenue Therapeutics, Inc. reported revenue of $1.4M and net income of -$2.9M. For detailed data — including Avenue Therapeutics, Inc. revenue history, earnings, dividends, and PE ratio — use the tabs above.
Frequently Asked Questions
As of the latest trading session, Avenue Therapeutics, Inc. (ATXI) stock price is $0.31. The stock is traded on OTC under the ticker symbol ATXI. The 52-week range is $0.15 – $0.97.